Your browser doesn't support javascript.
loading
Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.
Iwasaki, Yordkhwan W; Tharakaraman, Kannan; Subramanian, Vidya; Khongmanee, Amnart; Hatas, Andrew; Fleischer, Eduardo; Rurak, Troy T; Ngok-Ngam, Patchara; Tit-Oon, Phanthakarn; Ruchirawat, Mathuros; Satayavivad, Jutamaad; Fuangthong, Mayuree; Sasisekharan, Ram.
Afiliação
  • Iwasaki YW; Program in Environmental Toxicology, Chulabhorn Graduate Institute, Bangkok, Thailand.
  • Tharakaraman K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Subramanian V; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Khongmanee A; Translational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand.
  • Hatas A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Fleischer E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Rurak TT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Ngok-Ngam P; Translational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand.
  • Tit-Oon P; Translational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand.
  • Ruchirawat M; Translational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand.
  • Satayavivad J; Center of Excellence on Environmental Health and Toxicology (EHT), Office of the Permanent Secretary (OPS), Ministry of Higher Education, Science, Research and Innovation (MHESI), Bangkok, Thailand.
  • Fuangthong M; Program in Environmental Toxicology, Chulabhorn Graduate Institute, Bangkok, Thailand.
  • Sasisekharan R; Center of Excellence on Environmental Health and Toxicology (EHT), Office of the Permanent Secretary (OPS), Ministry of Higher Education, Science, Research and Innovation (MHESI), Bangkok, Thailand.
Front Immunol ; 13: 1063002, 2022.
Article em En | MEDLINE | ID: mdl-36703993
ABSTRACT
Bispecific antibodies (BsAbs) form an exciting class of bio-therapeutics owing to their multispecificity. Although numerous formats have been developed, generation of hetero-tetrameric IgG1-like BsAbs having acceptable safety and pharmacokinetics profiles from a single cell culture system remains challenging due to the heterogeneous pairing between the four chains. Herein, we employed a structure-guided approach to engineer mutations in the constant domain interfaces (CH1-CL and CH3-CH3) of heavy and κ light chains to prevent heavy-light mispairing in the antigen binding fragment (Fab) region and heavy-heavy homodimerization in the Fc region. Transient co-transfection of mammalian cells with heavy and light chains of pre-existing antibodies carrying the engineered constant domains generates BsAbs with percentage purity ranging from 78% to 85%. The engineered BsAbs demonstrate simultaneous binding of both antigens, while retaining the thermal stability, Fc-mediated effector properties and FcRn binding properties of the parental antibodies. Importantly, since the variable domains were not modified, the mutations may enable BsAb formation from antibodies belonging to different germline origins and isotypes. The rationally designed mutations reported in this work could serve as a starting point for generating optimized solutions required for large scale production.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article